Dr. Kevin J. Scanlon received his PhD in molecular biology at the University of London. Dr. Scanlon’s academic achievements include coauthoring 139 scientific articles and 9 medical books. He was a Leukemia Society Scholar and won the Paul Martini Medical Research Prize in Germany. He was cofounder and coeditor of the Nature Journal Cancer Gene Therapy and president of the International Society of Cell & Gene Therapy. Dr. Scanlon also holds seven issued U.S. patents. At Berlex-Schering AG (Berlin, Germany), he was responsible for the genomic and cancer programs in the United States, Europe, and Asia. As CEO of Melanoma Diagnostic, he sold his company to Myriad Genetics. When chairman of the Pasadena Angels, he was identified ...
Get The Hybrid Entrepreneur now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
